John Mendlein - Jan 19, 2023 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jan 19, 2023
Transactions value $
$38,992
Form type
4
Date filed
1/20/2023, 03:14 PM
Previous filing
Jan 13, 2023
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $39K +28.5K +10.07% $1.37 311K Jan 19, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 +28.5K $0.00* 0 Jan 19, 2023 Common Stock 28.5K $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option is fully vested and exercisable.